TNFRSF11A and neoplasm: Interestingly, after therapy with denosumab, that is used in humans for the treatment of unresectable GCTb, TRAP-positive cells decreased and became undetectable, suppressing tumor activity via inhibition of the RANK-RANKL pathway [41].